Search - tctmd.com

Displaying 1 - 20 of 98

Sort: Relevancy | Date

News Daily News

FDA Approves Two Additional Indications for Rivaroxaban in Children

L.A. McKeown

December 21, 2021

News Features

Cath Lab Teams Find Enduring Lessons in COVID-19’s Unending Reign

L.A. McKeown

December 20, 2021

News Features

World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard

Shelley Wood

December 13, 2021

News Daily News PCR London Valves 2021

Cardiologist Tests Positive for Omicron COVID-19 After Trip to PCR London Valves

Michael O'Riordan

December 01, 2021

News Conference News PCR London Valves 2021

Good Results but Small Numbers With JenaValve Trilogy in Severe AR

Michael O'Riordan

November 26, 2021

News Conference News PCR London Valves 2021

‘Reasonable’ Results With TMVR for Mitral Regurgitation: CHOICE-MI

Michael O'Riordan

November 25, 2021

News Conference News PCR London Valves 2021

Promising Early Results for TriClip in Tricuspid Regurgitation: bRIGHT Registry

Shelley Wood

November 24, 2021

News Daily News

US Aortic Valve Trends in Older Patients Hint at Better Outcomes, Access

L.A. McKeown

November 23, 2021

News Conference News AHA 2021

Lariat LAA Ligation Doesn’t Boost Effect of AF Ablation: aMAZE Trial

Todd Neale

November 18, 2021

News Daily News

Even in Big Cities, There Are Barriers to TAVI Access

Caitlin E. Cox

November 17, 2021

News Conference News AHA 2021

PALACS: Posterior Left Pericardiotomy Cuts Postop AF After Cardiac Surgery

Todd Neale

November 14, 2021

News Conference News TCT 2021

Transcatheter Mitral, Tricuspid Valve Replacement Inch Forward

Yael L. Maxwell

November 06, 2021

Presentation TCT 2021

DurAVR THV: A Novel 3D Single Piece Valve Designed for Improved Durability and Hemodynamics

Presenter: Samir Kapadia

November 05, 2021

News Conference News TCT 2021

More Complications With Plug Closure After TAVI: CHOICE-CLOSURE

Michael O'Riordan

November 05, 2021

News Conference News TCT 2021

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

Yael L. Maxwell

November 05, 2021

Presentation TCT 2021

Triluminate Registry: Lessons Learned for TEER Trial Design

Presenter: Georg Nickenig

November 04, 2021

Presentation TCT 2021

TCT 708: Left Anterior Descending Coronary Artery Occlusion After Balloon Aortic Valvuloplasty

Presenter: Mauro Gitto

November 04, 2021

News Daily News

Intravascular Lithotripsy May Facilitate TAVI in Patients With PAD

L.A. McKeown

November 04, 2021

News Daily News

Tendyne at 2 Years: Confirmed Feasibility but High Mortality With TMVR

Yael L. Maxwell

November 03, 2021

News Daily News

Bioresorbable PFO/ASD Closure Device Shows Promise, but More Research Needed

Yael L. Maxwell

November 02, 2021

Advertisement

FDA Approves Two Additional Indications for Rivaroxaban in Children

Cath Lab Teams Find Enduring Lessons in COVID-19’s Unending Reign

World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard

Cardiologist Tests Positive for Omicron COVID-19 After Trip to PCR London Valves

Good Results but Small Numbers With JenaValve Trilogy in Severe AR

‘Reasonable’ Results With TMVR for Mitral Regurgitation: CHOICE-MI

Promising Early Results for TriClip in Tricuspid Regurgitation: bRIGHT Registry

US Aortic Valve Trends in Older Patients Hint at Better Outcomes, Access

Lariat LAA Ligation Doesn’t Boost Effect of AF Ablation: aMAZE Trial

Even in Big Cities, There Are Barriers to TAVI Access

PALACS: Posterior Left Pericardiotomy Cuts Postop AF After Cardiac Surgery

Transcatheter Mitral, Tricuspid Valve Replacement Inch Forward

DurAVR THV: A Novel 3D Single Piece Valve Designed for Improved Durability and Hemodynamics

More Complications With Plug Closure After TAVI: CHOICE-CLOSURE

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

Triluminate Registry: Lessons Learned for TEER Trial Design

TCT 708: Left Anterior Descending Coronary Artery Occlusion After Balloon Aortic Valvuloplasty

Intravascular Lithotripsy May Facilitate TAVI in Patients With PAD

Tendyne at 2 Years: Confirmed Feasibility but High Mortality With TMVR

Bioresorbable PFO/ASD Closure Device Shows Promise, but More Research Needed

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content